Steve joined Skyline in May 2007, based in Boston. Prior to joining Skyline, he was a General Partner of TVM Capital. Steve was the founding President, Chief Executive Officer and a Director of Allos Therapeutics (NASDAQ: ALTH), Inc. where he is currently Chairman. He received his PhD from Northwestern University in chemistry and his MD from the University of Colorado. Dr. Hoffman completed a fellowship in clinical oncology and a residency and immunodermatology fellowship in dermatology, all at the University of Colorado. Steve is also a director of Sirtris Pharmaceuticals, Inc. Regarding our national pastime, he thinks the designated hitter is an abomination; still, he roots for the Red Sox but his son is a Yankee fan.